Article thumbnail

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma

By Zhouxun Chen, Suchen Gu, Bogusz Trojanowicz, Naxin Liu, Guanbao Zhu, Henning Dralle and Cuong Hoang-Vu
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated
  2. (1998). Akiyoshi T: Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res
  3. (2004). al: CD82 and CD63 in thyroid cancer.
  4. (2002). al: High Prevalence of Decreased Expression of KAI1 Metastasis Suppressor in Human Oral Carcinogenesis. Clin Cancer Res
  5. (1999). al: Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases. Surgery
  6. (2000). Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol
  7. (1996). Büchler MW: KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastasis. Cancer Res
  8. (1998). Büchler MW: Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
  9. (2001). Cell Mol Life Sci
  10. (2001). Complexes of tetraspanins with integrins: more than meets the eye.
  11. (1996). Correlation of CD82 gene expression with good prognosis in patients with nonsmall cell lung cancer. Cancer Re
  12. (1998). Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
  13. (2004). et al: Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
  14. (1996). et al: Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res
  15. (1995). et al: Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res
  16. (1995). JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science
  17. (1999). JC: Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res
  18. (1988). JH: Immunoglobulin and T-cell receptor gene rearrangement in blast crisis of chronic myelocytic leukemia. Exp Hematol
  19. (1999). KM: Shc and FAK differentially regulate cell motility and directionality modulated by PTEN.
  20. (2000). M: KAI1 Protein Is Down-Regulated during the Progression of Human Breast Cancer. Clin Cancer Res
  21. (2004). ME: EWI-2 modulates lymphocyte integrin a4β1fuctions. Blood
  22. (1988). Molecular cloning and characterization of an antigen associated with early stage of melanoma tumor progression. Cancer Res
  23. (1996). Motility-related protein-1 (MRP1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res
  24. (1999). Odintsova E: Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling.
  25. (1996). P: CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta1 integrins in human melanoma.
  26. (1997). PJ: Loss of KAI1 messenger RNA in both high grade and invasive human bladder cancers. Clin Cancer Res
  27. (2000). PJ: Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
  28. (1999). Rauman AG: Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
  29. (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line.
  30. (2001). Sánchez-Mateos P: Regulatory role of tetraspanin CD9 in tumorendothelial cell interaction during transendothelial invasion of melanoma cells. Blood
  31. (1993). Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med
  32. (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491).
  33. (2005). Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol
  34. (2000). Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration.
  35. (1997). The tetraspanin superfamily: molecular facilitators.
  36. (1994). Tomlinson MG: The ins and outs of the transmembrane 4 superfamily. Immunol Today
  37. (2006). Zhang XA: KAI1/CD82, a tumor metastasis suppressor. Cancer lett